Therapy Areas: Autoimmune
17 June 2019 - - US-based biotechnology company Genentech has received positive top line results from the Roche-sponsored Phase III PEMPHIX study evaluating the efficacy and safety of Rituxan (ri...
17 June 2019 - - US-based healthcare company Johnson and Johnson's (NYSE: JNJ) The Janssen Pharmaceutical Companies business has presented results of two analyses from a Phase 2 study of Stelara&...
17 June 2019 - - US-based orphan lung disease company Savara Inc. (NASDAQ: SVRA) has received disappointing top line data from IMPALA, a pivotal Phase 3 clinical study evaluating Molgradex, an in...
14 June 2019 - - US-based Celsius Therapeutics, a company translating single-cell genomic insights into precision therapeutics for patients with autoimmune diseases and cancer, has appointed Tariq Kas...
14 June 2019 - - US-based Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) has reported positive results from two studies in its Phase 1 programme evaluating CTP-692, a novel deuterium-modified form ...
14 June 2019 - - US-based biopharmaceutical company Prelude Therapeutics has secured USD 60m in series B financing; taking its total investments to date to USD 95m, the company said.
The financi...
Related Headlines